CompletedNCT05151913
The Microbiome Composition in Women With Recurring Intrahepatic Cholestasis of Pregnancy (ICP)
Studying Intrahepatic cholestasis of pregnancy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- MetaboGen AB
- Principal Investigator
- Helena Strevens, MD, PhDSkane University Hospital, Sweden
- Intervention
- Exploratory(other)
- Enrollment
- 105 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2017 – 2019
Study locations (2)
- Skane University Hospotal, Lund, Sweden
- Stockholm South General Hospital, Stockholm, Sweden
Collaborators
Skane University Hospital · Stockholm South General Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05151913 on ClinicalTrials.govOther trials for Intrahepatic cholestasis of pregnancy
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT06679972Impact of Intrahepatic Cholestasis of Pregnancy on Neonatal Respiratory OutcomesCarol Davila University of Medicine and Pharmacy
- RECRUITINGNCT07428226Serum Bile Acid Profiles in Patients With Intrahepatic Cholestasis of PregnancyJena University Hospital
- RECRUITINGNCT05197387Association of Intrahepatic Cholestasis of Pregnancy and Chronic Placental InflammationUniversity Hospital, Brest